Literature DB >> 29804651

Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells.

Gamze Tanriover1, Mehmet Berk Eyinc2, Elnur Aliyev3, Sayra Dilmac3, Nuray Erin4.   

Abstract

BACKGROUND: Increased S100A8/A9 expression in Gr1-positive cells has been shown in myeloid-derived suppressor cells and may play a role in the formation of a metastatic milieu. We aimed to determine S100A8/A9 expression alone and with coexpression of Gr1 (a myeloid marker) in primary tumor and visceral tissues invaded by metastatic breast carcinoma.
MATERIALS AND METHODS: Female BALB/c mice were injected with 4TLM, 4THM, and 67NR orthotopically. Confluent cells (75%-80%) were used. Primary tumor, lung, liver, and spleen tissue samples were removed 26 days after injection. Peripheral blood smears and metastasis assay were performed, as was immunohistochemistry and staining.
RESULTS: S100A8/A9 immunoreactivity alone or coexpressed with Gr1 was found in primary tumors formed by 4TLM and 4THM cells, which was markedly higher than in primary tumors formed by nonmetastatic 67NR cells. Similarly, liver and lung tissues obtained from mice injected with 4TLM or 4THM cells were invaded by S100A8/A9-positive and Gr1-positive cells. Double-positive cells were markedly fewer in liver and lung tissues of animals injected with 67NR cells. S100A8/A9-positive cells were mostly localized in red pulp of spleens. We observed an increased number of neutrophils in the peripheral blood of mice injected with metastatic breast carcinoma cells.
CONCLUSION: Tumor-derived factors may increase S100A8/A9-positive cells locally and systemically, and S100A8/A9-positive cells may provide an appropriate milieu for the formation of metastasis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; GR1; Immunohistochemistry; MDSC; S100A8/A9

Mesh:

Substances:

Year:  2018        PMID: 29804651     DOI: 10.1016/j.clbc.2018.03.013

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  5 in total

1.  S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.

Authors:  Ji-Sook Lee; Na Rae Lee; Ayesha Kashif; Seung-Ju Yang; A Reum Nam; Ik-Chan Song; Soo-Jung Gong; Min Hwa Hong; Geunyeong Kim; Pu Reum Seok; Myung-Shin Lee; Kee-Hyung Sung; In Sik Kim
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

Review 2.  Calprotectin in Lung Diseases.

Authors:  Ourania S Kotsiou; Dimitrios Papagiannis; Rodanthi Papadopoulou; Konstantinos I Gourgoulianis
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

3.  S100A8/A9 Molecular Complexes Promote Cancer Migration and Invasion via the p38 MAPK Pathway in Nasopharyngeal Carcinoma.

Authors:  Ning Xu; Bei-Bei Zhang; Xia-Ning Huang; Xiang Yi; Xue-Min Yan; Yan Cai; Qin He; Zi-Jian Han; Yuan-Jiao Huang; Wei Liu; Ai-Jun Jiao
Journal:  Bioinorg Chem Appl       Date:  2021-06-22       Impact factor: 7.778

4.  S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.

Authors:  Shuguang Pan; Ying Hu; Mengjia Hu; Yang Xu; Mo Chen; Changhong Du; Jinchi Cui; Ping Zheng; Jiejuan Lai; Yujun Zhang; Jie Bai; Peng Jiang; Jin Zhu; Yu He; Junping Wang
Journal:  Int J Oncol       Date:  2019-10-30       Impact factor: 5.650

5.  Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.

Authors:  Peitao Zhang; Haixia Guan; Shukai Yuan; Huili Cheng; Jian Zheng; Zhenlei Zhang; Yifan Liu; Yang Yu; Zhaowei Meng; Xiangqian Zheng; Li Zhao
Journal:  Nat Commun       Date:  2022-03-24       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.